Description
USAntibiotics's plant in Tennessee is one of the last plants in the United States that makes amoxicillin, the crucial antibiotic that has been in shortage in some forms since 2022. But the plant isn’t breaking even, financially. WSJ’s Liz Essley Whyte reports on why it is so hard for American-made generic drugs manufacturers to survive.
Further Listening:
- Will Florida’s Plan to Get Cheap Drugs From Canada Work?
- Trillion Dollar Shot
Further Reading:
- Drug Shortages in America Reach a Record High
- Drug Shortages Trigger FTC Probe
Learn more about your ad choices. Visit megaphone.fm/adchoices
Kyle, Texas is one of the fastest-growing cities in the United States. It is also facing heat and drought that has been exacerbated by climate change and is expected to get worse. Matt Wirz reports on the tensions in Kyle as the city continues to build, even as it runs low on water.
Further...
Published 09/06/24
Who will win the race to the White House? A new series from The Journal podcast explores the issues that are shaping this election. This week, Ryan Knutson and WSJ’s Molly Ball delve into reproductive rights, examining how the issue is playing out for both Democrats and Republicans. Plus..what...
Published 09/06/24